# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 4ylq:H (1.4) | BS01 | 0Z7 | 3.4.21.21 | GO:0004252 ... | P08709 | 26694616 | |
2 | 4ylq:H (1.4) | BS02 | CA | 3.4.21.21 | GO:0004252 ... | P08709 | 26694616 | |
3 | 4ylq:L (1.4) | BS01 | BGC | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 | |
4 | 4ylq:L (1.4) | BS02 | XYS | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 | |
5 | 4ylq:L (1.4) | BS03 | XYS | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 | |
6 | 4ylq:L (1.4) | BS04 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 | |
7 | 4ylq:L (1.4) | BS05 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 | |
8 | 4ylq:L (1.4) | BS06 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 | |
9 | 4ylq:L (1.4) | BS07 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 | |
10 | 4ylq:L (1.4) | BS08 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 | |
11 | 4ylq:L (1.4) | BS09 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 | |
12 | 4ylq:L (1.4) | BS10 | CA | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 | |
13 | 4ylq:L (1.4) | BS11 | FUC | 3.4.21.21 | GO:0005509 ... | P08709 | 26694616 |